Royalty Monetization Arrangement - Rollforward (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended	6 Months Ended
Jun. 30, 2025	Jun. 30, 2025	Jun. 30, 2025
Liability related to future royalties [Roll Forward]
Liability related to future royalties - beginning balance			$ 0
Liability related to future royalties - ending balance	$ 70,260	$ 70,260	70,260
Sagard Healthcare Partners \| Royalty Monetization Arrangement
Liability related to future royalties [Roll Forward]
Liability related to future royalties - beginning balance			0
Proceeds from sale of future royalties	70,000		70,000
Deferred transaction costs	(300)		(327)
Non-cash interest expense recognized		600	587
Liability related to future royalties - ending balance	$ 70,260	$ 70,260	$ 70,260

Amount of interest expense classified as nonoperating.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-4

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-14

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Name:	us-gaap_InterestExpenseNonoperating
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration